Resources

Introducing the QualityCare™ website, a freely available resource that provides direct answers to important questions about cancer associated thrombosis (CAT).

Recently launched by LEO Pharma, QualityCare™ takes a person-centred care approach which looks to provide patients and their carers with a variety of resources that discuss the link between blood clots and cancer, the risk and diagnosis of blood clots and post-treatment management.

 

Job code: UK/IE/MAT-06830
Date of preparation: February 2017

This communication was supported by LEO Pharma. LEO Pharma has no editorial control of Thrombus.

Please click here to view Annie Young's
(Professor of Nursing at University of Warwick & UHCW) thoughts on the website

 

Annie Young, Professor of Nursing at the University of Warwick and University Hospitals Coventry and Warwickshire had the following comments about QualityCare™:

QualityCare™ is a clear and well illustrated website, developed by LEO Pharma, elucidating the many aspects of cancer-associated thrombosis.

Communication about cancer and thrombosis is the golden key: QualityCare™ does this wonderfully well. It cuts straight to the chase – striving to increase awareness of the link between cancer and clots, to highlight the warning signs of both DVT and PE and to discuss the prevention of a clot. The website conveys person-centred care, and the highlight for me is the video, ‘Blood Clots, Cancer and You’, which is well executed and very accessible.

QualityCare™ has the potential to make a huge difference to patients’ understanding of the various clinical aspects of thrombosis and to their care.

Clinical Leaders of Thrombosis (CLOT) newsletters
CLOT newsletter - Spring/Summer 2014
CLOT newsletter – Autumn/Winter 2013

National Centre for Anticoagulation Training (NCAT)
Introduction to NCAT
Anticoagulation in Practice 2014 meeting report

Thrombus is funded by an unrestricted educational grant from Bayer HealthCare, with no editorial input into the contents of this journal.

Thrombus was previously supported by Boehringer Ingelheim from 2009 to 2013, by sanofi-aventis from 2007 to 2008 and by Leo Pharma from 1998 to 2006.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsor, publisher, Editor or Editorial Board. Accordingly the sponsor, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. Copyright © 2017 Hayward Group Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk

ISSN 1369-8117 (Print)  ISSN 2045-7855 (Online)